ASHLEY CHAPMAN: Open Payments
NPI 1467741108 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 24 payments from 11 companies in 2025. Trend: 2023 $293 · 2024 $524 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 6 | $153 |
| Gilead Sciences, Inc. | 5 | $131 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| Astellas Pharma US Inc | 2 | $41 |
| Theratechnologies Inc. | 1 | $34 |
| Shionogi Inc | 1 | $32 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| La Jolla Pharmaceutical Company | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $23 |
Products named: DOVATO, CABENUVA, Cresemba, RUKOBIA, PIFELTRO, EGRIFTA, Fetroja, NUZYRA.
Industry payments across SC — which companies pay providers there.
